126 related articles for article (PubMed ID: 1195281)
1. Synthesis and some pharmacological properties of [1-beta-mercapto-beta,beta-diethylpropionic acid,2-(3,5-dibromo-L-tyrosine)]oxytocin.
Lundell EO; Smith CW; Ferger MF
J Med Chem; 1975 Dec; 18(12):1262-4. PubMed ID: 1195281
[TBL] [Abstract][Full Text] [Related]
2. (1-Beta-mercaptopropionic acid, 2-(3,5-dibromo-L-tyrosine))oxytocin, a potent inhibitor of oxytocin.
Lundell EO; Ferger MF
J Med Chem; 1975 Oct; 18(10):1045-7. PubMed ID: 1159688
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and pharmacological properties of [1-L-penicillamine,4-L-leucine]oxytocin.
Ferger MF; Chan WY
J Med Chem; 1975 Oct; 18(10):1020-2. PubMed ID: 1159679
[TBL] [Abstract][Full Text] [Related]
4. (4-Phenylalanine)oxytocin, an inhibitor of the antidiuretic effect of 8-arginine-vasopressin.
Nestor JJ; Ferger MF; Chan WY
J Med Chem; 1975 Oct; 18(10):1022-4. PubMed ID: 1159680
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and some pharmacological properties of five analogs of oxytocin having L-homocysteine in position 6.
Smith CW; Ferger MF
J Med Chem; 1976 Feb; 19(2):250-4. PubMed ID: 1249804
[TBL] [Abstract][Full Text] [Related]
6. [1-Beta-mercapto-beta,beta-pentamethylenepropionic acid]oxytocin, a potent inhibitor of oxytocin.
Nestor JJ; Ferger MF; du Vigneaud V
J Med Chem; 1975 Mar; 18(3):284-7. PubMed ID: 1133819
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and some pharmacological properties of oxytocin analogues having L-thiazolidine-4-carboxylic acid in position 7.
Rosamond JD; Ferger MF
J Med Chem; 1976 Jul; 19(7):873-6. PubMed ID: 940106
[TBL] [Abstract][Full Text] [Related]
8. [1-Deaminopenicillamine,4-threonine]oxytocin, a potent inhibitor of oxytocin.
Manning M; Lowbridge J; Seto J; Haldar J; Sawyer WH
J Med Chem; 1978 Feb; 21(2):179-82. PubMed ID: 621712
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and some pharmacological properties of (3-beta-(2-thienyl)-L-alanine)-8-lysine-vasopressin.
Smith CW; Ferger MF; Chan WY
J Med Chem; 1975 Aug; 18(8):822-5. PubMed ID: 1171984
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and some pharmacological properties (4-beta-(2-thienyl)-L-alanine)oxytocin.
Smith CW; Skala G; Walter R
J Med Chem; 1978 Jan; 21(1):115-7. PubMed ID: 619140
[TBL] [Abstract][Full Text] [Related]
11. Synthetic antagonists of in vivo responses by the rat uterus to oxytocin.
Lowbridge J; Manning M; Seto J; Haldar J; Sawyer WH
J Med Chem; 1979 May; 22(5):565-9. PubMed ID: 458806
[TBL] [Abstract][Full Text] [Related]
12. (1-beta-mercapto-beta,beta-diethylpropionic acid,4-leucine)-8-lysine-vasopressin and (1-beta-mercapto-beta,beta-diethylpropionic acid,4-leucine)oxytocin, compounds possessing antihormonal properties.
Dyckes DF; Nestor JJ; Ferger MF; Du Vigneaud V; Chan WY
J Med Chem; 1974 Sep; 17(9):969-72. PubMed ID: 4855467
[No Abstract] [Full Text] [Related]
13. Replacement of the disulfide bond in oxytocin by an amide group. Synthesis and some biological properties of (cyclo-(1-L-aspartic acid,6-L-alpha,beta-diaminopropionic acid))oxytocin.
Smith CW; Walter R; Moore S; Makofske RC; Meienhofer J
J Med Chem; 1978 Jan; 21(1):117-20. PubMed ID: 619141
[TBL] [Abstract][Full Text] [Related]
14. Some pharmacological properties of cyclic and linear analogs obtained by substituting each residue of an oxytocin antagonist with D-tryptophan.
Flouret G; Brieher W; Majewski T; Mahan K; Wilson L
Int J Pept Protein Res; 1991 Aug; 38(2):169-75. PubMed ID: 1783491
[TBL] [Abstract][Full Text] [Related]
15. Active-site studies of neurohypophyseal hormones: synthesis and pharmacological properties of [5-(N4,N4-dimethylasparagine)]oxytocin.
Walter R; Stahl GL; Caplaneris T; Cordopatis P; Theodoropoulos D
J Med Chem; 1979 Jul; 22(7):890-3. PubMed ID: 448689
[TBL] [Abstract][Full Text] [Related]
16. Antagonists of oxytocin featuring replacement with modified beta-mercaptopropionic acids at position 1.
Flouret G; Majewski T; Balaspiri L; Brieher W; Mahan K; Chaloin O; Wilson L; Slaninová J
J Pept Sci; 2002 Jul; 8(7):314-26. PubMed ID: 12148781
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological effects of introducing a double bond into a binding site of oxytocin. Analogues with L-3,4-dehydroproline in position 7.
Moore S; Felix AM; Meienhofer J; Smith CW; Walter R
J Med Chem; 1977 Apr; 20(4):495-500. PubMed ID: 850234
[TBL] [Abstract][Full Text] [Related]
18. Biofunctional evaluation of a hydrogen bond linking the ring and tail beta-turns of oxytocin.
Roy J; Roy U; Gazis DC; Schwartz IL
Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3309-13. PubMed ID: 291004
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and some pharmacological properties of two new antagonists of oxytocin.
Rekowski P; Melin P; Lammek B
Pol J Pharmacol Pharm; 1987; 39(3):303-7. PubMed ID: 3438212
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and some pharmacological properties of 8-L-methionine-oxytocin.
Bodanszky M; Chandramouli N; Martinez J; Walter R
J Med Chem; 1979 Mar; 22(3):270-3. PubMed ID: 423209
[No Abstract] [Full Text] [Related]
[Next] [New Search]
